One of the most obvious effect of malaria is that it affects Malawi’s health services in that those people who are ill will need to be diagnosed, treatment and in some cases hospital admissions. This will then affect people from not going to work in their farming fields which will result in less or no food production and children being absent from school, which will have a direct effect to the social economy of the country. Sach (2007) suggested that diseases such as malaria are the key factors that trap developing countries to poverty.

Furthermore, high levels of absenteeism of children in schools will have an impact of improving literacy rates and the education system as a whole. Since under 5 children are the most affected by malaria in terms of deaths, these high mortality rates results in high fertility rates as more families will try and replace the children lost to malaria. This results in a fast growing population which can lead to high youth and adult unemployment.

  

 Phase 1:

 A new intervention was research tested in a small group of people in order to evaluate its side effects, safety and also to come up with a safe range of dosage

Phase 2: 

The intervention is now given to a larger group of people to find out if it is effective, evaluate its safety further and to finally select the required dosages.

Phase 3:

 The intervention eventually   given to a larger number of the targeted population to confirm its effectiveness. More information is collected that will determine whether the drug or treatment can be used safely.

Phase 4: 

 Further Studies are done after on the drug's effectiveness in different communities and any side effects due to long-term use.

 

The trial targeted 15000 young children and infants. Infants received the vaccine at 6, 10, and 14 weeks old while younger children received the vaccine between 5 and 17 months old. The trial they found that the younger children aged 5 and 17 months who received 3 doses of the vaccine reduced malaria cases by 39%, which is almost 4 out of 10 cases. While those on 4 doses of the vaccine reduced the malaria cases by 31.5%. However, those who did not receive the forth dose had a reduced protective benefit against malaria, meaning that the fourth dose is needed. The trial found that there was no protective benefits on infants with this vaccine (WHO, 2017)

 

 

Women getting tested for malaria

Sach. J (2007) work on the poverty trap. Available at http://www.malaria.com/questions/malaria-society-effects [accessed: 14/11/2017]
Taylor, T (2017) Malaria in Malawi. Available at https://www.google.co.uk/search?q=malaria+in+malawi+pictures&rlz=1C1GCEA_enGB779&tbm=isch&source=iu&ictx=1&fir=DlRI7_jKdaXK1M%253A%252C21BLn_5AdZwaEM%252C_&usg=__lWpED7Lhju6t6DQOZFTct3myRbE%3D&sa=X&ved=0ahUKEwj4rq_b6srYAhVDIlAKHTTXB28Q9QEINDAC#imgrc=xh1Je9jEukTs5M: [accessed: 07 January 2018]

The Malawi project (2017) statistics. Available at http://www.malawiproject.org/about-malawi/statistics/  [accessed: 07 November 2017

WHO (2017) Q&A on the Phase 3 trial results for malaria vaccine RTS, S/AS01. Available at http://www.who.int/malaria/media/rtss-phase-3-trial-qa/en/ [accessed: 14 November 2017]